Second Opinion October 8, 2025
We could be entering a future where we may see far fewer television ads featuring prescription pharmaceuticals. Consumers might applaud that, but as a longtime health and biotech industry journalist, I don’t think we’re talking nearly enough about the potential impact. It doesn’t just matter for pharma, but also for digital health companies that are starting to follow the playbook – and may be deterred from pursuing TV and streaming ads further.
“The administration’s recent actions have certainly created a moment of pause for the industry. Pharma companies are...







